Compugen Ltd. (CGEN)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Compugen Ltd. (CGEN)
Company Performance

Current Price

as of Oct 18, 2024

$1.71

P/E Ratio

N/A

Market Cap

$153.11M

Description

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.

Metrics

Overview

  • HQHolon, TA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerCGEN
  • Price$1.71-1.16%

Trading Information

  • Market Cap$153.11M
  • Float94.62%
  • Average Daily Volume (1m)211,263
  • Average Daily Volume (3m)232,253
  • EPS-$0.11

Company

  • Revenue$42.72M
  • Rev Growth (1yr)N/A
  • Net Income-$2.12M
  • Gross Margin76.84%
  • EBITDA MarginN/A
  • EBITDAN/A
  • EV$61.11M
  • EV/Revenue1.43
  • P/EN/A
  • P/S3.58
  • P/B2.62
Documents
Factset Street Account
StreetAccount Earnings Call Q&A Summary: Compugen Q3 (2023-11-21T15:45:32Z)
Compugen will be eligible to receive $10M milestone payment upon dosing of first patient in AstraZeneca Phase 3 rilvegostomig trial in biliary tract cancer ($0.73, 0.00) (2023-12-19T12:13:04Z)
Compugen to host conference call at 8:30 AM ET to discuss exclusive license agreement with Gilead for COM503 ($0.73, 0.00) (2023-12-19T12:07:00Z)
Compugen reports Q3 EPS ($0.11) vs FactSet ($0.10) [4 est, ($0.12)-(0.04)] ($0.72, 0.00) (2023-11-07T12:11:43Z)
Compugen announces new Japanese patent for the triple combination of any Anti-PVRIG, TIGIT and PD-1 antibody for the treatment of cancer ($0.93, 0.00) (2023-10-02T11:05:04Z)
Compugen announces data presented at SITC - 6-K ($0.74, 0.00) (2023-11-06T12:09:27Z)
Earnings Calls
Earnings Report 2024Q1
Earnings Report 2023Q4
Earnings Report (2023-11-07)
Earnings Report (2023-08-07)
Factset
Factset Business Description